Molecular Design Strategy to Construct the Near-Infrared Fluorescent Probe for Selectively Sensing Human Cytochrome P450 2J2

被引:166
作者
Ning, Jing [1 ,2 ]
Liu, Tao [2 ]
Dong, Peipei [1 ]
Wang, Wei [3 ]
Ge, Guangbo [4 ]
Wang, Bo [1 ]
Yu, Zhenlong [1 ]
Shi, Lei [1 ]
Tian, Xiangge [1 ]
Huo, Xiaokui [1 ]
Feng, Lei [1 ,2 ]
Wang, Chao [1 ]
Sun, Chengpeng [1 ]
Cui, Jingnan [2 ]
James, Tony D. [5 ]
Ma, Xiaochi [1 ]
机构
[1] Dalian Med Univ, Coll Pharm, Natl & Local Joint Engn Res Ctr Drug Dev Neurodeg, Coll Integrat Med, Dalian 116044, Peoples R China
[2] Dalian Univ Technol, State Key Lab Fine Chem, Dalian 116024, Peoples R China
[3] Hunan Univ Chinese Med, Sch Pharm, Sino Pakistan TCM & Ethnomed Res Ctr 8, TCM & Ethnomed Innovat & Dev Int Lab, Changsha 410208, Hunan, Peoples R China
[4] Shanghai Univ Tradit Chinese Med, Inst Interdisciplinary Integrat Med Res, Shanghai 201203, Peoples R China
[5] Univ Bath, Dept Chem, Bath BA2 7AY, Avon, England
基金
中国国家自然科学基金;
关键词
SOLUBLE EPOXIDE HYDROLASE; LIVING CELLS; IN-VITRO; CANCER; ANGIOGENESIS; CYP2J2; PROMOTES; METABOLISM; THERAPY; P450;
D O I
10.1021/jacs.8b12136
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Cytochrome P450 2J2 (CYP2J2), a key enzyme responsible for oxidative metabolism of various xenobiotics and endogenous compounds, participates in a diverse array of physiological and pathological processes in humans. Its biological role in tumorigenesis and cancer diagnosis remains poorly understood, owing to the lack of molecular tools suitable for real-time monitoring CYP2J2 in complex biological systems. Using molecular design principles, we were able to modify the distance between the catalytic unit and metabolic recognition moiety, allowing us to develop a CYP2J2 selective fluorescent probe using a near-infrared fluorophore (E)-2-(2-(6-hydroxy-2,3-dihydro-1H-xanthen-4-yl)vinyl)-3,3-dimethyl-1-propyl-3H-indol-1-ium iodide (HXPI). To improve the reactivity and isoform specificity, a self-immolative linker was introduced to the HXPI derivatives in order to better fit the narrow substrate channel of CYP2J2, the modification effectively shortened the spatial distance between the metabolic moiety (O-alkyl group) and catalytic center of CYP2J2. After screening a panel of O-alkylated HXPI derivatives, BnXPI displayed the best combination of specificity, sensitivity and applicability for detecting CYP2J2 in vitro and in vivo. Upon O-demethylation by CYP2J2, a self-immolative reaction occurred spontaneously via 1,6-elimination of p-hydroxybenzyl resulting in the release of HXPI. Allowing BnXPI to be successfully used to monitor CYP2J2 activity in real-time for various living systems including cells, tumor tissues, and tumor-bearing animals. In summary, our practical strategy could help the development of a highly specific and broadly applicable tool for monitoring CYP2J2, which offers great promise for exploring the biological functions of CYP2J2 in tumorigenesis.
引用
收藏
页码:1126 / 1134
页数:9
相关论文
共 49 条
[1]   Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries [J].
Allemani, Claudia ;
Matsuda, Tomohiro ;
Di Carlo, Veronica ;
Harewood, Rhea ;
Matz, Melissa ;
Niksic, Maja ;
Bonaventure, Audrey ;
Valkov, Mikhail ;
Johnson, Christopher J. ;
Esteve, Jacques ;
Ogunbiyi, Olufemi J. ;
Azevedo e Silva, Gulnar ;
Chen, Wan-Qing ;
Eser, Sultan ;
Engholm, Gerda ;
Stiller, Charles A. ;
Monnereau, Alain ;
Woods, Ryan R. ;
Visser, Otto ;
Lim, Gek Hsiang ;
Aitken, Joanne ;
Weir, Hannah K. ;
Coleman, Michel P. .
LANCET, 2018, 391 (10125) :1023-1075
[2]   Roles of the epoxygenase CYP2J2 in the endothelium [J].
Askari, Ara ;
Thomson, Scott J. ;
Edin, Matthew L. ;
Zeldin, Darryl C. ;
Bishop-Bailey, David .
PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2013, 107 :56-63
[3]   Angiogenesis in cancer and other diseases [J].
Carmeliet, P ;
Jain, RK .
NATURE, 2000, 407 (6801) :249-257
[4]   Cytochrome P450 2J2 Is Highly Expressed in Hematologic Malignant Diseases and Promotes Tumor Cell Growth [J].
Chen, Chen ;
Wei, Xin ;
Rao, Xiaoquan ;
Wu, Jun ;
Yang, Shenglan ;
Chen, Fuqiong ;
Ma, Ding ;
Zhou, Jianfeng ;
Dackor, Ryan T. ;
Zeldin, Darryl C. ;
Wang, Dao Wen .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2011, 336 (02) :344-355
[5]   Selective Inhibitors of CYP2J2 Related to Terfenadine Exhibit Strong Activity against Human Cancers in Vitro and in Vivo [J].
Chen, Chen ;
Li, Guiling ;
Liao, Wanmin ;
Wu, Jun ;
Liu, Liu ;
Ma, Ding ;
Zhou, Jianfeng ;
Elbekai, Reem H. ;
Edin, Matthew L. ;
Zeldin, Darryl C. ;
Wang, Dao Wen .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 329 (03) :908-918
[6]   A Highly Selective Ratiometric Two-Photon Fluorescent Probe for Human Cytochrome P450 1A [J].
Dai, Zi-Ru ;
Ge, Guang-Bo ;
Feng, Lei ;
Ning, Jing ;
Hu, Liang-Hai ;
Jin, Qiang ;
Wang, Dan-Dan ;
Lv, Xia ;
Dou, Tong-Yi ;
Cui, Jing-Nan ;
Yang, Ling .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2015, 137 (45) :14488-14495
[7]   Cytochrome P450 2J2, a new key enzyme in cyclophosphamide bioactivation and a potential biomarker for hematological malignancies [J].
El-Serafi, I. ;
Fares, M. ;
Abedi-Valugerdi, M. ;
Afsharian, P. ;
Moshfegh, A. ;
Terelius, Y. ;
Potacova, Z. ;
Hassan, M. .
PHARMACOGENOMICS JOURNAL, 2015, 15 (05) :405-413
[8]   Distribution of soluble epoxide hydrolase, cytochrome P4502C8, 2C9 and 2J2 in human malignant neoplasms [J].
Enayetallah, Ahmed E. ;
French, Richard A. ;
Grant, David F. .
JOURNAL OF MOLECULAR HISTOLOGY, 2006, 37 (3-4) :133-141
[9]   ANGIOGENESIS IN CANCER, VASCULAR, RHEUMATOID AND OTHER DISEASE [J].
FOLKMAN, J .
NATURE MEDICINE, 1995, 1 (01) :27-31
[10]   Structural features of cytochromes P450 and ligands that affect drug metabolism as revealed by x-ray crystallography and NMR [J].
Gay, Sean C. ;
Roberts, Arthur G. ;
Halpert, James R. .
FUTURE MEDICINAL CHEMISTRY, 2010, 2 (09) :1451-1468